{"id":608067,"date":"2026-04-16T13:36:08","date_gmt":"2026-04-16T13:36:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/608067\/"},"modified":"2026-04-16T13:36:08","modified_gmt":"2026-04-16T13:36:08","slug":"lillys-obesity-pill-helps-reduce-cardiovascular-risks-in-late-stage-trial","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/608067\/","title":{"rendered":"Lilly&#8217;s obesity pill helps reduce cardiovascular risks in late-stage trial"},"content":{"rendered":"<p>Eli Lilly Foundayo GLP-1 weight loss pill.<\/p>\n<p>Courtesy: Eli Lilly<\/p>\n<p><a href=\"https:\/\/www.cnbc.com\/quotes\/LLY\/\" rel=\"nofollow noopener\" target=\"_blank\">Eli Lilly<\/a> said on Thursday its newly approved obesity pill helped reduce the risk of major cardiovascular events at a similar rate as insulin glargine in adults with type 2 diabetes and obesity, meeting the main goal of a long late-stage trial.<\/p>\n<p>In the study of more than 2,700 adults, patients taking Foundayo had a 16% lower risk of heart attack, stroke or cardiovascular death, and a 57% lower risk of death from any cause compared with those on insulin glargine.<\/p>\n<p>Patients taking Foundayo also saw bigger drops in blood sugar and weight after a year, while those on insulin glargine gained weight, the company said.<\/p>\n<p>Lilly said it will seek U.S. approval of Foundayo for type 2 diabetes under the Commissioner&#8217;s National Priority Review Voucher, and will submit an application for it by the end of the second quarter.<\/p>\n<p><a href=\"https:\/\/www.google.com\/preferences\/source?q=https:\/\/www.cnbc.com\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Eli Lilly Foundayo GLP-1 weight loss pill. Courtesy: Eli Lilly Eli Lilly said on Thursday its newly approved&hellip;\n","protected":false},"author":2,"featured_media":608068,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[1234,45,161,49,48,1237,84,1235,392],"class_list":{"0":"post-608067","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-biotech-and-pharmaceuticals","9":"tag-business","10":"tag-business-news","11":"tag-ca","12":"tag-canada","13":"tag-eli-lilly-and-co","14":"tag-health","15":"tag-health-care-industry","16":"tag-healthcare"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/608067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=608067"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/608067\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/608068"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=608067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=608067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=608067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}